Tributyltin chloride induces ABCA1 expression and apolipoprotein A-I-mediated cellular cholesterol efflux by activating LXRalpha/RXR

被引:32
作者
Cui, Hongyan
Okuhira, Keiichiro
Ohoka, Nobumichi
Naito, Mikihiko
Kagechika, Hiroyuki [3 ]
Hirose, Akihiko [2 ]
Nishimaki-Mogami, Tomoko [1 ]
机构
[1] Natl Inst Hlth Sci, Div Biochem & Mol Biol, Setagaya Ku, Tokyo 1588501, Japan
[2] Natl Inst Hlth Sci, Div Risk Assessment, Tokyo 1588501, Japan
[3] Tokyo Med & Dent Univ, Sch Biomed Sci, Tokyo, Japan
基金
日本学术振兴会;
关键词
Tributyltin chloride; Retinoid X receptor; Liver X receptor; ABCA1; HDL; RETINOID-X-RECEPTOR; ORGANOTIN COMPOUNDS; ENDOCRINE DISRUPTION; AROMATASE INHIBITOR; NUCLEAR RECEPTORS; GENE-EXPRESSION; ATHEROSCLEROSIS; HETERODIMERS; DISEASE; TRIPHENYLTIN;
D O I
10.1016/j.bcp.2010.12.023
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Organotins, including tri-butyltin chloride (TBTC), are widely used in agricultural and chemical industries and cause persistent and widespread pollution. TBTC has been shown to activate nuclear receptor retinoid X receptor (RXR)/PPAR gamma signaling by interacting with RXR to modulate adipogenesis. However, whether TBTC affects liver X receptor (LXR)/RXR activity and subsequently the expression of cholesterol mobilizing genes is not known. In this study, we evaluated the ability of TBTC to activate LXR/RXR and ABC transporter A1 (ABCA1) expression. ABCA1 plays a critical role in HDL generation, maintaining cholesterol homeostasis, and cholesterol accumulation-induced diseases, such as atherosclerosis and pancreatic islet dysfunction. In a reporter gene assay, TBTC activated LXR alpha/RXR but not LXR beta/RXR. In mouse macrophage RAW264 cells, TBTC activated the ABCA1 promoter in an LXR-responsive element dependent manner and increased ABCA1 mRNA expression. TBTC augmented ABCA1 protein levels and apolipoprotein A-I-dependent cellular cholesterol efflux (HDL generation). The LXR-target fatty acid synthase and Spa mRNA levels were also increased by TBTC exposure. We conclude that TBTC has the ability to activate permissive LXR alpha/RXR signaling and thereby modulate cellular cholesterol efflux. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:819 / 824
页数:6
相关论文
共 35 条
[1]
Characterization of apolipoprotein-mediated HDL generation induced by cAMP in a murine macrophage cell line [J].
Abe-Dohmae, S ;
Suzuki, S ;
Wada, Y ;
Aburatani, H ;
Vance, DE ;
Yokoyama, S .
BIOCHEMISTRY, 2000, 39 (36) :11092-11099
[2]
Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages [J].
Aiello, RJ ;
Brees, D ;
Bourassa, PA ;
Royer, L ;
Lindsey, S ;
Coskran, T ;
Haghpassand, M ;
Francone, OL .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (04) :630-637
[3]
RAR and RXR modulation in cancer and metabolic disease [J].
Altucci, Lucia ;
Leibowitz, Mark D. ;
Ogilvie, Kathleen M. ;
de Lera, Angel R. ;
Gronemeyer, Hinrich .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (10) :793-810
[4]
ABCA1: at the nexus of cholesterol, HDL and atherosclerosis [J].
Attie, Alan D. .
TRENDS IN BIOCHEMICAL SCIENCES, 2007, 32 (04) :172-179
[5]
β-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment [J].
Brunham, Liam R. ;
Kruit, Janine K. ;
Pape, Terry D. ;
Timmins, Jenelle M. ;
Reuwer, Anne Q. ;
Vasanji, Zainisha ;
Marsh, Brad J. ;
Rodrigues, Brian ;
Johnson, James D. ;
Parks, John S. ;
Verchere, C. Bruce ;
Hayden, Michael R. .
NATURE MEDICINE, 2007, 13 (03) :340-347
[6]
Liver X Receptor Signaling Pathways and Atherosclerosis [J].
Calkin, Anna C. ;
Tontonoz, Peter .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (08) :1513-1518
[7]
Nuclear receptors and lipid physiology: Opening the X-files [J].
Chawla, A ;
Repa, JJ ;
Evans, RM ;
Mangelsdorf, DJ .
SCIENCE, 2001, 294 (5548) :1866-1870
[8]
Costet P, 2000, J BIOL CHEM, V275, P28240
[9]
FURTHER EVALUATION OF THE DEVELOPMENTAL TOXICITY OF TRIBUTYLTIN CHLORIDE IN RATS [J].
EMA, M ;
KUROSAKA, R ;
AMANO, H ;
OGAWA, Y .
TOXICOLOGY, 1995, 96 (03) :195-201
[10]
Liver X receptor modulators: Effects on lipid metabolism and potential use in the treatment of atherosclerosis [J].
Fievet, C. ;
Staels, B. .
BIOCHEMICAL PHARMACOLOGY, 2009, 77 (08) :1316-1327